This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.


Edita Botonjic-Sehic, Ph.D.
Sr. Manager, Process Analytical Technology (PAT) at Pall Corporation


Dr. Edita Botonjic-Sehic, a graduate of Assumption College with BA degrees in chemistry and mathematics and the University of Rhode Island with a PhD in the field of Analytical Chemistry.  Dr. Botonjic-Sehic joined Pall Corporation in 2016 and is currently Sr. Manager, Process Analytical Technology (PAT).  In her current position, she is responsible for conceptualization and implementation of process analytical technology (PAT) in continuous bioprocessing.  With a PhD program concentrating in spectroscopy and chemometrics and multiple years in PAT, Dr. Botonjic-Sehic brings a highly refined experience to the table.  This experience includes over 15 years of research in spectroscopy and chemometrics for PAT and the development and utilization of advanced analytical techniques in pharmaceutical, biotechnolgoy and homeland security arenas. More specifically, Dr. Botonjic-Sehic was a member of the PAT team within GlaxoSmithKline’s program for API development and has also lead a PAT team at TEVA pharmaceuticals for drug product manufacturing.  In addition to those positions, she was also principal investigator (PI) and a program manager on several government funded (DHS, TSWG, CTTSO) projects at Morpho Detection, specifically working on the development of systems for the detection of trace and bulk materials.  An author of a number of papers as well as talks in the field of spectroscopy and chemometrics, pharmaceuticals and homeland security; Dr. Botonjic-Sehic continues to be a leader in her field.

Agenda Sessions

  • Advanced technologies and computational modeling in continuous bioprocessing